Embecta Corp. — Investor Relations & Filings

Embecta Corp. is a global medical device company focused on improving the health and well-being of people living with diabetes. As one of the largest pure-play diabetes care companies, it leverages a nearly 100-year legacy in insulin delivery. The company's core business involves the manufacturing and distribution of insulin delivery devices, primarily pen needles and insulin syringes, which are used by over 30 million people in more than 100 countries. Embecta is also committed to providing educational resources and support on proper injection techniques to the global diabetes community.